Rezumat.
Obiective. Sublinierea importanței testării periodice la markerii hepatitelor virale pentru pacienții urologici, ca măsură crucială pentru gestionarea
adecvată a infecțiilor.
Metode. A fost efectuat un studiu epidemiologic descriptiv transversal (cross-secțional). De la bolnavii secției de urologie a Spitalului Clinic
Republican ”Timofei Moșneaga” au fost prelevate probe de sânge pentru examinarea acestora prin metoda imuno-enzimatică (ELISA) la markerii
hepatitelor virale: anti-HAV, anti-HAV IgM, AgHBs, anti-HBcor, anti-HBs, anti-HCV, anti-HEV IgG și anti-HEV IgM. În total au fost examinați 234
bolnavi, fiind efectuate 1638 investigații de laborator.
Rezultate. La bolnavii din secția de urologie a Spitalului Clinic Republican ”Timofei Moșneaga” au fost identificate următoarele nivele de
seroprevalență a markerilor hepatitelor virale: AgHBs – 9,0±1,9%; anti-HBcor – 47,9±3,3%; anti-HBs – 41,0±3,2%; anti-HCV – 7,7±1,7%; antiHAV – 95,3±1,4%; anti-HAV IgM – 0%; anti-HEV IgG – 17,5±2,5%; anti-HEV IgM – 27,4±2,9%. Cele mai afectate grupuri pentru hepatitele B și C
au fost persoanele de gen feminin din zona de Centru a țării, iar pentru hepatita E – persoanele de gen masculin provenite din zona de Nord.
Concluzii. Rezultatele obținute denotă faptul, că pacienții urologici pot fi considerați ca un grup la risc sporit de infectare cu virusurile hepatitelor
B, C și E.
Summary.
Objectives. Emphasizing the importance of periodic testing for viral hepatitis markers in urology patients as a crucial measure for proper infection
management.
Methods. A cross-sectional descriptive epidemiological study was conducted. Blood samples were collected from patients in the urology department
of the Republican Clinical Hospital and examined using enzyme-linked immunosorbent assay (ELISA) for the following viral hepatitis markers:
anti-HAV, anti-HAV IgM, AgHBs, anti-HBcor, anti-HBs, anti-HCV, anti-HEV IgG and anti-HEV IgM. A total of 234 patients were examined, and 1638
laboratory tests were performed.
Results. The following seroprevalence levels of viral hepatitis markers were identified among patients in the urology department of”Timofei
Moșneaga” Republican Clinical Hospital: AgHBs – 9.0±1.9%; anti-HBcor –47.9±3.3%; anti-HBs – 41.0±3.2%; anti-HCV – 7.7±1.7%; anti-HAV
– 95.3±1.4%; anti-HAV IgM – 0%; anti-HEV IgG – 17.5±2.5%; anti-HEV IgM – 27.4±2.9%. The most affected groups for hepatitis B and C were
females from the central region of the country, while for hepatitis E – males from the northern region were the most affected.
Conclusions. The results indicate that urological patients can be considered a group at increased risk of infection with hepatitis B, C, and E viruses.
